ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies

April 25, 1986

NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen

December 4, 1987

Additional DCE Contract Concepts

November 16, 1984

ASCO honors physicians for clinical trials participation.

June 4, 2004